Dr. Lisa Ramaut from the Department of Plastic, Reconstructive, and Aesthetic Surgery at the Brussels University Hospital (UZ ...

Agomab’s ALK5 inhibitor has proven its ability to target the correct part of the intestine in a phase 2 trial of ...

A recent study showed that paracrine delivery of miR-21a-5p by bone marrow mesenchymal stem cells-derived apoptotic bodies ...

Whenever you get a cut, an injury, big or small, your body immediately goes into the process of healing it. So, how does it ...

Colon cancer continues to be one of the leading causes of cancer-related deaths worldwide, with poor dietary habits ...

and MIMEDX to provide advanced products for consistent wound management. In addition to the VALUE study, MediWound is preparing for a head-to-head Phase II study comparing EscharEx to collagenase ...

A new study has revealed that ferulic acid, a natural compound found in various plant-based foods, can significantly inhibit the growth and migration of colon cancer cells at different stages of ...

The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or dead tissue from chronic wounds in multiple Phase II trials.